麻豆原创 Analysis and Insights: Global Diabetic Tests 麻豆原创
The global Diabetic Tests market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents鈥� wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
Report Covers:
This report presents an overview of global market for Diabetic Tests market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Diabetic Tests, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Diabetic Tests, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Diabetic Tests revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Diabetic Tests market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Diabetic Tests revenue, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
Medtronic
Abbott Laboratories
Bayer Healthcare AG.
B. Braun
Terumo Corporation
Acon Laboratories
Roche Diagnostics
闯辞丑苍蝉辞苍锛咼辞丑苍蝉辞苍
ARKRAY
Novo Nordisk
Ypsomed
Sanofi
LifeScan
I-SENS
Omron
Segment by Type
Blood Glucose Monitor
Diabetes Test Strip
Others
Segment by Application
Hospital
Clinic
麻豆原创 Care
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Diabetic Tests in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetic Tests companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diabetic Tests revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Diabetic Tests 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Blood Glucose Monitor
1.2.3 Diabetes Test Strip
1.2.4 Others
1.3 麻豆原创 by Application
1.3.1 Global Diabetic Tests 麻豆原创 Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 麻豆原创 Care
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetic Tests 麻豆原创 Perspective (2019-2030)
2.2 Global Diabetic Tests Growth Trends by Region
2.2.1 Diabetic Tests 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Diabetic Tests Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Diabetic Tests Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Diabetic Tests 麻豆原创 Dynamics
2.3.1 Diabetic Tests Industry Trends
2.3.2 Diabetic Tests 麻豆原创 Drivers
2.3.3 Diabetic Tests 麻豆原创 Challenges
2.3.4 Diabetic Tests 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Diabetic Tests by Players
3.1.1 Global Diabetic Tests Revenue by Players (2019-2024)
3.1.2 Global Diabetic Tests Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Diabetic Tests 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Diabetic Tests, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Diabetic Tests 麻豆原创 Concentration Ratio
3.4.1 Global Diabetic Tests 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetic Tests Revenue in 2023
3.5 Global Key Players of Diabetic Tests Head office and Area Served
3.6 Global Key Players of Diabetic Tests, Product and Application
3.7 Global Key Players of Diabetic Tests, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetic Tests Breakdown Data by Type
4.1 Global Diabetic Tests Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Diabetic Tests Forecasted 麻豆原创 Size by Type (2025-2030)
5 Diabetic Tests Breakdown Data by Application
5.1 Global Diabetic Tests Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Diabetic Tests Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Diabetic Tests 麻豆原创 Size (2019-2030)
6.2 North America Diabetic Tests 麻豆原创 Size by Type
6.2.1 North America Diabetic Tests 麻豆原创 Size by Type (2019-2024)
6.2.2 North America Diabetic Tests 麻豆原创 Size by Type (2025-2030)
6.2.3 North America Diabetic Tests 麻豆原创 Share by Type (2019-2030)
6.3 North America Diabetic Tests 麻豆原创 Size by Application
6.3.1 North America Diabetic Tests 麻豆原创 Size by Application (2019-2024)
6.3.2 North America Diabetic Tests 麻豆原创 Size by Application (2025-2030)
6.3.3 North America Diabetic Tests 麻豆原创 Share by Application (2019-2030)
6.4 North America Diabetic Tests 麻豆原创 Size by Country
6.4.1 North America Diabetic Tests 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Diabetic Tests 麻豆原创 Size by Country (2019-2024)
6.4.3 North America Diabetic Tests 麻豆原创 Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Diabetic Tests 麻豆原创 Size (2019-2030)
7.2 Europe Diabetic Tests 麻豆原创 Size by Type
7.2.1 Europe Diabetic Tests 麻豆原创 Size by Type (2019-2024)
7.2.2 Europe Diabetic Tests 麻豆原创 Size by Type (2025-2030)
7.2.3 Europe Diabetic Tests 麻豆原创 Share by Type (2019-2030)
7.3 Europe Diabetic Tests 麻豆原创 Size by Application
7.3.1 Europe Diabetic Tests 麻豆原创 Size by Application (2019-2024)
7.3.2 Europe Diabetic Tests 麻豆原创 Size by Application (2025-2030)
7.3.3 Europe Diabetic Tests 麻豆原创 Share by Application (2019-2030)
7.4 Europe Diabetic Tests 麻豆原创 Size by Country
7.4.1 Europe Diabetic Tests 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Diabetic Tests 麻豆原创 Size by Country (2019-2024)
7.4.3 Europe Diabetic Tests 麻豆原创 Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Diabetic Tests 麻豆原创 Size (2019-2030)
8.2 China Diabetic Tests 麻豆原创 Size by Type
8.2.1 China Diabetic Tests 麻豆原创 Size by Type (2019-2024)
8.2.2 China Diabetic Tests 麻豆原创 Size by Type (2025-2030)
8.2.3 China Diabetic Tests 麻豆原创 Share by Type (2019-2030)
8.3 China Diabetic Tests 麻豆原创 Size by Application
8.3.1 China Diabetic Tests 麻豆原创 Size by Application (2019-2024)
8.3.2 China Diabetic Tests 麻豆原创 Size by Application (2025-2030)
8.3.3 China Diabetic Tests 麻豆原创 Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Diabetic Tests 麻豆原创 Size (2019-2030)
9.2 Asia Diabetic Tests 麻豆原创 Size by Type
9.2.1 Asia Diabetic Tests 麻豆原创 Size by Type (2019-2024)
9.2.2 Asia Diabetic Tests 麻豆原创 Size by Type (2025-2030)
9.2.3 Asia Diabetic Tests 麻豆原创 Share by Type (2019-2030)
9.3 Asia Diabetic Tests 麻豆原创 Size by Application
9.3.1 Asia Diabetic Tests 麻豆原创 Size by Application (2019-2024)
9.3.2 Asia Diabetic Tests 麻豆原创 Size by Application (2025-2030)
9.3.3 Asia Diabetic Tests 麻豆原创 Share by Application (2019-2030)
9.4 Asia Diabetic Tests 麻豆原创 Size by Region
9.4.1 Asia Diabetic Tests 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Diabetic Tests 麻豆原创 Size by Region (2019-2024)
9.4.3 Asia Diabetic Tests 麻豆原创 Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Diabetic Tests 麻豆原创 Size (2019-2030)
10.2 Middle East, Africa, and Latin America Diabetic Tests 麻豆原创 Size by Type
10.2.1 Middle East, Africa, and Latin America Diabetic Tests 麻豆原创 Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Diabetic Tests 麻豆原创 Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Diabetic Tests 麻豆原创 Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Diabetic Tests 麻豆原创 Size by Application
10.3.1 Middle East, Africa, and Latin America Diabetic Tests 麻豆原创 Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Diabetic Tests 麻豆原创 Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Diabetic Tests 麻豆原创 Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Diabetic Tests 麻豆原创 Size by Country
10.4.1 Middle East, Africa, and Latin America Diabetic Tests 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Diabetic Tests 麻豆原创 Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Diabetic Tests 麻豆原创 Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Diabetic Tests Introduction
11.1.4 Medtronic Revenue in Diabetic Tests Business (2019-2024)
11.1.5 Medtronic Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Diabetic Tests Introduction
11.2.4 Abbott Laboratories Revenue in Diabetic Tests Business (2019-2024)
11.2.5 Abbott Laboratories Recent Developments
11.3 Bayer Healthcare AG.
11.3.1 Bayer Healthcare AG. Company Details
11.3.2 Bayer Healthcare AG. Business Overview
11.3.3 Bayer Healthcare AG. Diabetic Tests Introduction
11.3.4 Bayer Healthcare AG. Revenue in Diabetic Tests Business (2019-2024)
11.3.5 Bayer Healthcare AG. Recent Developments
11.4 B. Braun
11.4.1 B. Braun Company Details
11.4.2 B. Braun Business Overview
11.4.3 B. Braun Diabetic Tests Introduction
11.4.4 B. Braun Revenue in Diabetic Tests Business (2019-2024)
11.4.5 B. Braun Recent Developments
11.5 Terumo Corporation
11.5.1 Terumo Corporation Company Details
11.5.2 Terumo Corporation Business Overview
11.5.3 Terumo Corporation Diabetic Tests Introduction
11.5.4 Terumo Corporation Revenue in Diabetic Tests Business (2019-2024)
11.5.5 Terumo Corporation Recent Developments
11.6 Acon Laboratories
11.6.1 Acon Laboratories Company Details
11.6.2 Acon Laboratories Business Overview
11.6.3 Acon Laboratories Diabetic Tests Introduction
11.6.4 Acon Laboratories Revenue in Diabetic Tests Business (2019-2024)
11.6.5 Acon Laboratories Recent Developments
11.7 Roche Diagnostics
11.7.1 Roche Diagnostics Company Details
11.7.2 Roche Diagnostics Business Overview
11.7.3 Roche Diagnostics Diabetic Tests Introduction
11.7.4 Roche Diagnostics Revenue in Diabetic Tests Business (2019-2024)
11.7.5 Roche Diagnostics Recent Developments
11.8 闯辞丑苍蝉辞苍锛咼辞丑苍蝉辞苍
11.8.1 闯辞丑苍蝉辞苍锛咼辞丑苍蝉辞苍 Company Details
11.8.2 闯辞丑苍蝉辞苍锛咼辞丑苍蝉辞苍 Business Overview
11.8.3 闯辞丑苍蝉辞苍锛咼辞丑苍蝉辞苍 Diabetic Tests Introduction
11.8.4 闯辞丑苍蝉辞苍锛咼辞丑苍蝉辞苍 Revenue in Diabetic Tests Business (2019-2024)
11.8.5 闯辞丑苍蝉辞苍锛咼辞丑苍蝉辞苍 Recent Developments
11.9 ARKRAY
11.9.1 ARKRAY Company Details
11.9.2 ARKRAY Business Overview
11.9.3 ARKRAY Diabetic Tests Introduction
11.9.4 ARKRAY Revenue in Diabetic Tests Business (2019-2024)
11.9.5 ARKRAY Recent Developments
11.10 Novo Nordisk
11.10.1 Novo Nordisk Company Details
11.10.2 Novo Nordisk Business Overview
11.10.3 Novo Nordisk Diabetic Tests Introduction
11.10.4 Novo Nordisk Revenue in Diabetic Tests Business (2019-2024)
11.10.5 Novo Nordisk Recent Developments
11.11 Ypsomed
11.11.1 Ypsomed Company Details
11.11.2 Ypsomed Business Overview
11.11.3 Ypsomed Diabetic Tests Introduction
11.11.4 Ypsomed Revenue in Diabetic Tests Business (2019-2024)
11.11.5 Ypsomed Recent Developments
11.12 Sanofi
11.12.1 Sanofi Company Details
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Diabetic Tests Introduction
11.12.4 Sanofi Revenue in Diabetic Tests Business (2019-2024)
11.12.5 Sanofi Recent Developments
11.13 LifeScan
11.13.1 LifeScan Company Details
11.13.2 LifeScan Business Overview
11.13.3 LifeScan Diabetic Tests Introduction
11.13.4 LifeScan Revenue in Diabetic Tests Business (2019-2024)
11.13.5 LifeScan Recent Developments
11.14 I-SENS
11.14.1 I-SENS Company Details
11.14.2 I-SENS Business Overview
11.14.3 I-SENS Diabetic Tests Introduction
11.14.4 I-SENS Revenue in Diabetic Tests Business (2019-2024)
11.14.5 I-SENS Recent Developments
11.15 Omron
11.15.1 Omron Company Details
11.15.2 Omron Business Overview
11.15.3 Omron Diabetic Tests Introduction
11.15.4 Omron Revenue in Diabetic Tests Business (2019-2024)
11.15.5 Omron Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Medtronic
Abbott Laboratories
Bayer Healthcare AG.
B. Braun
Terumo Corporation
Acon Laboratories
Roche Diagnostics
闯辞丑苍蝉辞苍锛咼辞丑苍蝉辞苍
ARKRAY
Novo Nordisk
Ypsomed
Sanofi
LifeScan
I-SENS
Omron
听
听
*If Applicable.
